Facial Fat Transfer Market

By Transfer Target Area (Naso-Labial Folds, Lips, Marionette Folds, Temples, Under-Eye Area, Chin)
By Treatment (Dermal Fillers, Fat Injection, Others), By Donor Area (Thigh, Abdomen, Flank),
By End Use (Hospitals, Cosmetic Surgery Clinics),
By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa):

Global Analysis and Forecast 2023-2033

Base Year
2022
|
Forecast Timeframe:
2023 to 2033
|
Data Tables:
318
|
Number of Figures
183
|
Expert Contributions

The facial fat transfer market showcased a revenue of USD 2.3 billion in 2022 and is projected to witness a compounded annual growth rate (CAGR) of more than 10.2 % over the forecast period of 2023-2033.

1.      Introduction

1.1    Report Description

1.1.1 Definition

1.1.2 Abbreviations

1.2    Key Market Segments

1.3    Benefits to Stakeholders

1.4    Research Methodology

1.4.1 Market Scoping

1.4.1.1   Problem Identification
1.4.1.2   Defining the Market

1.4.2 Market Estimation

1.4.2.1   Data Mining
1.4.2.2   Product Analysis
1.4.2.3   Application Analysis
1.4.2.4   Market Engineering and Forecasting
1.4.2.4.1  Bottom-up Demand Side
1.4.2.4.2  Bottom-up Supply side

1.4.3 Market Authentication

1.4.3.1   Data Triangulation
1.4.3.1.1  Top-down Supply Side
1.4.3.1.2  Top-down Demand Side
1.4.3.1.3  Data Triangulation
1.4.3.2   Primary Insights and Industry feedback

1.4.4 Report Writing

2. Executive Summary

2.3 Primary Insights

2.4 Transfer Target Area Insights

2.5 Treatment Insights

2.6 Donor Area Insights

2.7 End Use Insights

2.8 Regional Insights

3. Market Overview

3.1 Market Segment and Scope

3.2 Top Investment Pockets

3.3 Key Strategic Initiatives

3.4 Facial Fat Transfer Market Industry Ecosystem

3.5 Market Evolution

3.6 Patent Analysis

3.7 Technology Landscape

3.8 Regulatory Infrastructure

3.9 Porter’s Analysis

3.9.1 Bargaining Power of Buyer

3.9.2 Bargaining Power of Supplier

3.9.3 Threat of New Entrants

3.9.4 Threat of Substitutes

3.9.5 Industry Rivalry

3.10 PESTLE Analysis

3.11 Market Dynamics

3.11.1 Drivers

3.11.2 Restrains

3.11.3 Opportunities

3.12 Impact of COVID-19 on Facial Fat Transfer Market

3.13 Russia-Ukraine War Impact on Facial Fat Transfer Market

3.14 Growth Share Matrix

3.15 Facial Fat Transfer Market Quadrant

4. Facial Fat Transfer Market, By Transfer Target Area

4.1 Major Impacting Factors, By Transfer Target Area

4.1.1 Key Market Trends and Growth Factors

4.1.2 Market Size and Forecast, by Region, 2017-2032, (USD Billion)

4.1.3 Market Size and Forecast, by Country, 2017-2032, (USD Billion)

4.2 Naso-Labial Folds

4.2.1 Key Market Trends and Growth Factors

4.2.2 Market Size and Forecast, by Region, 2017-2032, (USD Billion)

4.2.3 Market Size and Forecast, by Country, 2017-2032, (USD Billion)

4.3 Lips

4.3.1 Key Market Trends and Growth Factors

4.3.2 Market Size and Forecast, by Region, 2017-2032, (USD Billion)

4.3.3 Market Size and Forecast, by Country, 2017-2032, (USD Billion)

4.4 Marionette Folds

4.4.1 Key Market Trends and Growth Factors

4.4.2 Market Size and Forecast, by Region, 2017-2032, (USD Billion)

4.4.3 Market Size and Forecast, by Country, 2017-2032, (USD Billion)

4.5 Temples

4.5.1 Key Market Trends and Growth Factors

4.5.2 Market Size and Forecast, by Region, 2017-2032, (USD Billion)

4.5.3 Market Size and Forecast, by Country, 2017-2032, (USD Billion)

4.6 Under-Eye Area

4.6.1 Key Market Trends and Growth Factors

4.6.2 Market Size and Forecast, by Region, 2017-2032, (USD Billion)

4.6.3 Market Size and Forecast, by Country, 2017-2032, (USD Billion)

4.7 Chin

4.7.1 Key Market Trends and Growth Factors

4.7.2 Market Size and Forecast, by Region, 2017-2032, (USD Billion)

4.7.3 Market Size and Forecast, by Country, 2017-2032, (USD Billion)

5. Facial Fat Transfer Market, By Treatment

5.1 Major Impacting Factors, By Treatment

5.1.1 Key Market Trends and Growth Factors

5.1.2 Market Size and Forecast, by Region, 2017-2032, (USD Billion)

5.1.3 Market Size and Forecast, by Country, 2017-2032, (USD Billion)

5.2 Dermal Fillers

5.2.1 Key Market Trends and Growth Factors

5.2.2 Market Size and Forecast, by Region, 2017-2032, (USD Billion)

5.2.3 Market Size and Forecast, by Country, 2017-2032, (USD Billion)

5.3 Fat Injection

5.3.1 Key Market Trends and Growth Factors

5.3.2 Market Size and Forecast, by Region, 2017-2032, (USD Billion)

5.3.3 Market Size and Forecast, by Country, 2017-2032, (USD Billion)

5.4 Others

5.4.1 Key Market Trends and Growth Factors

5.4.2 Market Size and Forecast, by Region, 2017-2032, (USD Billion)

5.4.3 Market Size and Forecast, by Country, 2017-2032, (USD Billion)

6. Facial Fat Transfer Market, By Donor Area

6.1 Major Impacting Factors, By Donor Arean

6.1.1 Key Market Trends and Growth Factors

6.1.2 Market Size and Forecast, by Region, 2017-2032, (USD Billion)

6.1.3 Market Size and Forecast, by Country, 2017-2032, (USD Billion)

6.2 Thigh

6.2.1 Key Market Trends and Growth Factors

6.2.2 Market Size and Forecast, by Region, 2017-2032, (USD Billion)

6.2.3 Market Size and Forecast, by Country, 2017-2032, (USD Billion)

6.3 Abdomen

6.3.1 Key Market Trends and Growth Factors

6.3.2 Market Size and Forecast, by Region, 2017-2032, (USD Billion)

6.3.3 Market Size and Forecast, by Country, 2017-2032, (USD Billion)

6.4 Flank

6.4.1 Key Market Trends and Growth Factors

6.4.2 Market Size and Forecast, by Region, 2017-2032, (USD Billion)

6.4.3 Market Size and Forecast, by Country, 2017-2032, (USD Billion)

7. Facial Fat Transfer Market, By End Use

7.1 Major Impacting Factors, By End Use

7.1.1 Key Market Trends and Growth Factors

7.1.2 Market Size and Forecast, by Region, 2017-2032, (USD Billion)

7.1.3 Market Size and Forecast, by Country, 2017-2032, (USD Billion)

7.2 Hospitals

7.2.1 Key Market Trends and Growth Factors

7.2.2 Market Size and Forecast, by Region, 2017-2032, (USD Billion)

7.2.3 Market Size and Forecast, by Country, 2017-2032, (USD Billion)

7.3 Cosmetic Surgery Clinics

7.3.1 Key Market Trends and Growth Factors

7.3.2 Market Size and Forecast, by Region, 2017-2032, (USD Billion)

7.3.3 Market Size and Forecast, by Country, 2017-2032, (USD Billion)

8. Facial Fat Transfer Market, By Region

8.1 Global Market Trends and Growth Factors

8.2 Market Size and Forecast, by Transfer Target Area, 2017-2032, (USD Billion)

8.3 Market Size and Forecast, by Treatment, 2017-2032, (USD Billion)

8.4 Market Size and Forecast, by Donor Area, 2017-2032, (USD Billion)

8.5 Market Size and Forecast, by End Use, 2017-2032, (USD Billion)

8.6 Market Size and Forecast, by Region, 2017-2032, (USD Billion)

8.7 North America

8.7.1 Key Market Trends and Growth Factors

8.7.2 Market Size and Forecast, by Transfer Target Area, 2017-2032, (USD Billion)

8.7.3 Market Size and Forecast, by Treatment, 2017-2032, (USD Billion)

8.7.4 Market Size and Forecast, by Donor Area, 2017-2032, (USD Billion)

8.7.5 Market Size and Forecast, by End Use, 2017-2032, (USD Billion)

8.7.6 Market Size and Forecast, by Country, 2017-2032, (USD Billion)

8.7.7 U.S.

8.7.7.1 Market Size and Forecast, by Transfer Target Area, 2017-2032, (USD Billion)
8.7.7.2 Market Size and Forecast, by Treatment, 2017-2032, (USD Billion)
8.7.7.3 Market Size and Forecast, by Donor Area, 2017-2032, (USD Billion)
8.7.7.4 Market Size and Forecast, by End Use, 2017-2032, (USD Billion)

8.7.8 Canada

8.7.8.1 Market Size and Forecast, by Transfer Target Area, 2017-2032, (USD Billion)
8.7.8.2 Market Size and Forecast, by Treatment, 2017-2032, (USD Billion)
8.7.8.3 Market Size and Forecast, by Donor Area, 2017-2032, (USD Billion)
8.7.8.4 Market Size and Forecast, by End Use, 2017-2032, (USD Billion)

8.7.9 Mexico

8.7.9.1 Market Size and Forecast, by Transfer Target Area, 2017-2032, (USD Billion)
8.7.9.2 Market Size and Forecast, by Treatment, 2017-2032, (USD Billion)
8.7.9.3 Market Size and Forecast, by Donor Area, 2017-2032, (USD Billion)
8.7.9.4 Market Size and Forecast, by End Use, 2017-2032, (USD Billion)

8.8 Europe

8.8.1 Key Market Trends and Growth Factors

8.8.2 Market Size and Forecast, by Transfer Target Area, 2017-2032, (USD Billion)

8.8.3 Market Size and Forecast, by Treatment, 2017-2032, (USD Billion)

8.8.4 Market Size and Forecast, by Donor Area, 2017-2032, (USD Billion)

8.8.5 Market Size and Forecast, by End Use, 2017-2032, (USD Billion)

8.8.6 Market Size and Forecast, by Country, 2017-2032, (USD Billion)

8.8.7 UK

8.8.7.1 Market Size and Forecast, by Transfer Target Area, 2017-2032, (USD Billion)
8.8.7.2 Market Size and Forecast, by Treatment, 2017-2032, (USD Billion)
8.8.7.3 Market Size and Forecast, by Donor Area, 2017-2032, (USD Billion)
8.8.7.4 Market Size and Forecast, by End Use, 2017-2032, (USD Billion)

8.8.8 Germany

8.8.8.1 Market Size and Forecast, by Transfer Target Area, 2017-2032, (USD Billion)
8.8.8.2 Market Size and Forecast, by Treatment, 2017-2032, (USD Billion)
8.8.8.3 Market Size and Forecast, by Donor Area, 2017-2032, (USD Billion)
8.8.8.4 Market Size and Forecast, by End Use, 2017-2032, (USD Billion)

8.8.9 France

8.8.9.1 Market Size and Forecast, by Transfer Target Area, 2017-2032, (USD Billion)
8.8.9.2 Market Size and Forecast, by Treatment, 2017-2032, (USD Billion)
8.8.9.3 Market Size and Forecast, by Donor Area, 2017-2032, (USD Billion)
8.8.9.4 Market Size and Forecast, by End Use, 2017-2032, (USD Billion)

8.8.10 Russia

8.8.10.1 Market Size and Forecast, by Transfer Target Area, 2017-2032, (USD Billion)
8.8.10.2 Market Size and Forecast, by Treatment, 2017-2032, (USD Billion)
8.8.10.3 Market Size and Forecast, by Donor Area, 2017-2032, (USD Billion)
8.8.10.4 Market Size and Forecast, by End Use, 2017-2032, (USD Billion)

8.8.11 Italy

8.8.11.1 Market Size and Forecast, by Transfer Target Area, 2017-2032, (USD Billion)
8.8.11.2 Market Size and Forecast, by Treatment, 2017-2032, (USD Billion)
8.8.11.3 Market Size and Forecast, by Donor Area, 2017-2032, (USD Billion)
8.8.11.4 Market Size and Forecast, by End Use, 2017-2032, (USD Billion)

8.8.12 Rest of Europe

8.8.12.1 Market Size and Forecast, by Transfer Target Area, 2017-2032, (USD Billion)
8.8.12.2 Market Size and Forecast, by Treatment, 2017-2032, (USD Billion)
8.8.12.3 Market Size and Forecast, by Donor Area, 2017-2032, (USD Billion)
8.8.12.4 Market Size and Forecast, by End Use, 2017-2032, (USD Billion)

8.9 Asia-Pacific

8.9.1 Key Market Trends and Growth Factors

8.9.2 Market Size and Forecast, by Transfer Target Area, 2017-2032, (USD Billion)

8.9.3 Market Size and Forecast, by Treatment, 2017-2032, (USD Billion)

8.9.4 Market Size and Forecast, by Donor Area, 2017-2032, (USD Billion)

8.9.5 Market Size and Forecast, by End Use, 2017-2032, (USD Billion)

8.9.6 Market Size and Forecast, by Country, 2017-2032, (USD Billion)

8.9.7 China

8.9.7.1 Market Size and Forecast, by Transfer Target Area, 2017-2032, (USD Billion)
8.9.7.2 Market Size and Forecast, by Treatment, 2017-2032, (USD Billion)
8.9.7.3 Market Size and Forecast, by Donor Area, 2017-2032, (USD Billion)
8.9.7.4 Market Size and Forecast, by End Use, 2017-2032, (USD Billion)

8.9.8 India

8.9.8.1 Market Size and Forecast, by Transfer Target Area, 2017-2032, (USD Billion)
8.9.8.2 Market Size and Forecast, by Treatment, 2017-2032, (USD Billion)
8.9.8.3 Market Size and Forecast, by Donor Area, 2017-2032, (USD Billion)
8.9.8.4 Market Size and Forecast, by End Use, 2017-2032, (USD Billion)

8.9.9 Japan

8.9.9.1 Market Size and Forecast, by Transfer Target Area, 2017-2032, (USD Billion)
8.9.9.2 Market Size and Forecast, by Treatment, 2017-2032, (USD Billion)
8.9.9.3 Market Size and Forecast, by Donor Area, 2017-2032, (USD Billion)
8.9.9.4 Market Size and Forecast, by End Use, 2017-2032, (USD Billion)

8.9.10 Australia

8.9.10.1 Market Size and Forecast, by Transfer Target Area, 2017-2032, (USD Billion)
8.9.10.2 Market Size and Forecast, by Treatment, 2017-2032, (USD Billion)
8.9.10.3 Market Size and Forecast, by Donor Area, 2017-2032, (USD Billion)
8.9.10.4 Market Size and Forecast, by End Use, 2017-2032, (USD Billion)

8.9.11 Rest of Asia-Pacific

8.9.11.1 Market Size and Forecast, by Transfer Target Area, 2017-2032, (USD Billion)
8.9.11.2 Market Size and Forecast, by Treatment, 2017-2032, (USD Billion)
8.9.11.3 Market Size and Forecast, by Donor Area, 2017-2032, (USD Billion)
8.9.11.4 Market Size and Forecast, by End Use, 2017-2032, (USD Billion)

8.10 Latin America

8.10.1 Key Market Trends and Growth Factors

8.10.2 Market Size and Forecast, by Transfer Target Area, 2017-2032, (USD Billion)

8.10.3 Market Size and Forecast, by Treatment, 2017-2032, (USD Billion)

8.10.4 Market Size and Forecast, by Donor Area, 2017-2032, (USD Billion)

8.10.5 Market Size and Forecast, by End Use, 2017-2032, (USD Billion)

8.10.6 Market Size and Forecast, by Country, 2017-2032, (USD Billion)

8.10.7 Brazil

8.10.7.1 Market Size and Forecast, by Transfer Target Area, 2017-2032, (USD Billion)
8.10.7.2 Market Size and Forecast, by Treatment, 2017-2032, (USD Billion)
8.10.7.3 Market Size and Forecast, by Donor Area, 2017-2032, (USD Billion)
8.10.7.4 Market Size and Forecast, by End Use, 2017-2032, (USD Billion)

8.10.8 Argentina

8.10.8.1 Market Size and Forecast, by Transfer Target Area, 2017-2032, (USD Billion)
8.10.8.2 Market Size and Forecast, by Treatment, 2017-2032, (USD Billion)
8.10.8.3 Market Size and Forecast, by Donor Area, 2017-2032, (USD Billion)
8.10.8.4 Market Size and Forecast, by End Use, 2017-2032, (USD Billion)

8.10.9 Mexico

8.10.9.1 Market Size and Forecast, by Transfer Target Area, 2017-2032, (USD Billion)
8.10.9.2 Market Size and Forecast, by Treatment, 2017-2032, (USD Billion)
8.10.9.3 Market Size and Forecast, by Donor Area, 2017-2032, (USD Billion)
8.10.9.4 Market Size and Forecast, by End Use, 2017-2032, (USD Billion)

8.10.10 Chile

8.10.10.1 Market Size and Forecast, by Transfer Target Area, 2017-2032, (USD Billion)
8.10.10.2 Market Size and Forecast, by Treatment, 2017-2032, (USD Billion)
8.10.10.3 Market Size and Forecast, by Donor Area, 2017-2032, (USD Billion)
8.10.10.4 Market Size and Forecast, by End Use, 2017-2032, (USD Billion)

8.11 Middle East and Africa

8.11.1 Key Market Trends and Growth Factors

8.11.2 Market Size and Forecast, by Transfer Target Area, 2017-2032, (USD Billion)

8.11.3 Market Size and Forecast, by Treatment, 2017-2032, (USD Billion)

8.11.4 Market Size and Forecast, by Donor Area, 2017-2032, (USD Billion)

8.11.5 Market Size and Forecast, by End Use, 2017-2032, (USD Billion)

8.11.6 Market Size and Forecast, by Country, 2017-2032, (USD Billion)

8.11.7 South Africa

8.11.7.1 Market Size and Forecast, by Transfer Target Area, 2017-2032, (USD Billion)
8.11.7.2 Market Size and Forecast, by Treatment, 2017-2032, (USD Billion)
8.11.7.3 Market Size and Forecast, by Donor Area, 2017-2032, (USD Billion)
8.11.7.4 Market Size and Forecast, by End Use, 2017-2032, (USD Billion)

8.11.8 UAE

8.11.8.1 Market Size and Forecast, by Transfer Target Area, 2017-2032, (USD Billion)
8.11.8.2 Market Size and Forecast, by Treatment, 2017-2032, (USD Billion)
8.11.8.3 Market Size and Forecast, by Donor Area, 2017-2032, (USD Billion)
8.11.8.4 Market Size and Forecast, by End Use, 2017-2032, (USD Billion)

8.11.9 Saudi Arabia

8.11.9.1 Market Size and Forecast, by Transfer Target Area, 2017-2032, (USD Billion)
8.11.9.2 Market Size and Forecast, by Treatment, 2017-2032, (USD Billion)
8.11.9.3 Market Size and Forecast, by Donor Area, 2017-2032, (USD Billion)
8.11.9.4 Market Size and Forecast, by End Use, 2017-2032, (USD Billion)

8.11.10 Israel

8.11.10.1 Market Size and Forecast, by Transfer Target Area, 2017-2032, (USD Billion)
8.11.10.2 Market Size and Forecast, by Treatment, 2017-2032, (USD Billion)
8.11.10.3 Market Size and Forecast, by Donor Area, 2017-2032, (USD Billion)
8.11.10.4 Market Size and Forecast, by End Use, 2017-2032, (USD Billion)

9. Competitive Benchmarking & Company Profiles

9.1 Competitive Benchmarking

9.1.1 Company Market Share

9.1.2 Product Mapping

9.1.3 Competitive Heat map

9.2 Allergan Plc

9.2.1 Company Overview

9.2.2 Financial Analysis

9.2.3 Product Offering

9.2.4 Strategic Initiatives

9.2.5 SWOT

9.2.6 Ansoff Matrix

9.3 Bausch Health Companies Inc

9.3.1 Company Overview

9.3.2 Financial Analysis

9.3.3 Product Offering

9.3.4 Strategic Initiatives

9.3.5 SWOT

9.3.6 Ansoff Matrix

9.4 Cytori Therapeutics, Inc.

9.4.1 Company Overview

9.4.2 Financial Analysis

9.4.3 Product Offering

9.4.4 Strategic Initiatives

9.4.5 SWOT

9.4.6 Ansoff Matrix

9.5 DR. Korman

9.5.1 Company Overview

9.5.2 Financial Analysis

9.5.3 Product Offering

9.5.4 Strategic Initiatives

9.5.5 SWOT

9.5.6 Ansoff Matrix

9.6 Galderma Laboratories, L.P.

9.6.1 Company Overview

9.6.2 Financial Analysis

9.6.3 Product Offering

9.6.4 Strategic Initiatives

9.6.5 SWOT

9.6.6 Ansoff Matrix

9.7 Integra LifeSciences Corporation

9.7.1 Company Overview

9.7.2 Financial Analysis

9.7.3 Product Offering

9.7.4 Strategic Initiatives

9.7.5 SWOT

9.7.6 Ansoff Matrix

9.8 Medikan International Inc

9.8.1 Company Overview

9.8.2 Financial Analysis

9.8.3 Product Offering

9.8.4 Strategic Initiatives

9.8.5 SWOT

9.8.6 Ansoff Matrix

9.9 Stanford Health Care

9.9.1 Company Overview

9.9.2 Financial Analysis

9.9.3 Product Offering

9.9.4 Strategic Initiatives

9.9.5 SWOT

9.9.6 Ansoff Matrix

9.10 SciVision Biotech Inc

9.10.1 Company Overview

9.10.2 Financial Analysis

9.10.3 Product Offering

9.10.4 Strategic Initiatives

9.10.5 SWOT

9.10.6 Ansoff Matrix

9.11 Teoxane Laboratories

9.11.1 Company Overview

9.11.2 Financial Analysis

9.11.3 Product Offering

9.11.4 Strategic Initiatives

9.11.5 SWOT

9.11.6 Ansoff Matrix

10. Industry Connects and Upcoming Seminars

REPORT CODE
HCP21983
PUBLISHED ON
April 2023
REQUEST A FREE SAMPLE
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
BUY NOW
SCHEDULE A CONSULTING CALL